Abstract: The present invention provides sustained-release opiate compositions. In particular, the present invention provides sustained-release opiate compositions that include an opiate attached to a blood albumin binder. The present invention also relates to methods of administering an opiate with a sustained release pharmacokinetic profile.
Abstract: The present invention provides an efficient process for the preparation of hexahydroisoquinolines from dihydroisoquinolines. In particular, the invention provides a good yielding, one-pot process for the synthesis of hexahydroisoquinolines.
Type:
Application
Filed:
September 24, 2010
Publication date:
March 24, 2011
Applicant:
Mallinckrodt Inc.
Inventors:
Christopher W. Grote, Frank W. Moser, Peter X. Wang, Gary L. Cantrell, David W. Berberich
Abstract: A medical device includes a conduit for a fluid. The conduit has a wall formed of a hydrophobic polymer with a hydrophilic polymer layer extruded over it, and an antimicrobial substantially dispersed within the hydrophilic polymer. The antimicrobial compound may be a predetermined amount of phosphorus-based glass having a predetermined quantity of a metal such as silver substantially dispersed therein. The medical device may be an endotracheal tube made by providing a hydrophobic polymer, a hydrophilic polymer and an antimicrobial compound, forming the hydrophobic polymer, the hydrophilic polymer and the antimicrobial compound into a conduit, and forming a cuff on an end of the conduit.
Type:
Application
Filed:
December 1, 2010
Publication date:
March 24, 2011
Applicant:
Mallinckrodt Inc.
Inventors:
Paul W. Martens, Robert L. Nieto, Robert Virag, Adin M. Potter
Abstract: The present disclosure generally relates to methods for producing opioid derivatives. More particularly, the present disclosure relates to the preparation of hydromorphone, hydrocodone, or a derivative thereof, by means of a non-catalytic hydrogenation reaction of thebaine, oripavine or a derivative thereof, respectively, using a hydrazide reagent, followed by hydrolysis of the hydrogenated intermediate at a low temperature and for a short period of time. Additionally, the present disclosure relates to a composition comprising the desired hydromorphone, hydrocodone, or a derivative thereof, in combination with a 6-beta compound that is structurally related thereto.
Abstract: The present disclosure generally relates to catalytic methods for producing opioid derivatives. More particularly, the present disclosure relates to the preparation of hydrocodone, hydromorphone, or a derivative thereof, by means of a conversion or an isomerization of codeine, morphine, or a derivative thereof, respectively, using a heterogeneous ruthenium metal catalyst.
Abstract: The present invention provides processes for the preparation of 10-keto and/or 10-hydroxy morphinans. In particular, the invention provides to processes for preparing a 10-keto morphinan by chromium-catalyzed benzylic oxidation of a morphinan with a periodic acid.
Type:
Application
Filed:
September 7, 2010
Publication date:
March 24, 2011
Applicant:
Mallinckrodt Inc.
Inventors:
Hang Sun, John E. Johnson, JR., Ricky L. Fenton, Sarah M. Dorn
Abstract: The present invention provides an efficient process for the preparation of hexahydroisoquinolines from amides. In particular, the invention provides a good yielding, one-pot process for the synthesis of hexahydroisoquinolines.
Type:
Application
Filed:
September 24, 2010
Publication date:
March 24, 2011
Applicant:
Mallinckrodt Inc.
Inventors:
Christopher W. Grote, Frank W. Moser, Peter X. Wang, Gary L. Cantrell, David W. Berberich
Abstract: Embodiments of the present invention include systems and methods that relate to pulse oximetry. Specifically, one embodiment includes an oximeter sensor, comprising a light emitting element configured to emit light, a light detector configured to receive the light, and a memory device that stores data, comprising an amount of wetness on the oximeter sensor.
Abstract: The present invention relates to compounds having the general formula: Y-L-BFR-X wherein BFR is a bridged fused ring system; Y is a targeting group; L is optionally present and is a linker for coupling Y to BFR; and X is halogen (e.g., radiohalogen) or a functional group for labelling.
Type:
Grant
Filed:
January 30, 2006
Date of Patent:
March 8, 2011
Assignee:
Mallinckrodt Inc.
Inventors:
Jacobus Donatus M. Herscheid, Joost Verbeek
Abstract: The present invention relates to management of information relating to medical fluids, containers therefore, and medical fluid administration devices for administering such medical fluids to patients. Data tags (e.g., RFID tags) are generally associated with containers of the invention and may be electromagnetically read from and/or written to using an electromagnetic device, for example, that may be associated with a medical fluid administration device of the invention.
Type:
Grant
Filed:
December 29, 2006
Date of Patent:
March 1, 2011
Assignee:
Mallinckrodt Inc.
Inventors:
Frank M. Fago, David W. Wilson, Chad M. Gibson, William E. Bausmith, Vernon D. Ortenzi, Elaine E. Haynes, Elaine F. Borgemenke, John H. Lewis, Gary S. Wagner
Abstract: Embodiments of the present invention relate to a sensor for facilitating detection of a physiological characteristic of a patient. Specifically, one embodiment includes a detector configured to obtain signals from the patient, the signals being indicative of the physiological characteristic, an interface configured to send the signals to a monitor, and a sensor memory coupled with the sensor and separate from the monitor, the sensor memory storing sensor expiration data.
Type:
Grant
Filed:
June 1, 2006
Date of Patent:
February 1, 2011
Assignee:
Mallinckrodt Inc.
Inventors:
Paul D. Mannheimer, Michael E. Fein, Marcia Fein, legal representative
Abstract: The present invention provides (+)-morphinans comprising Toll-like receptor 9 (TLR9) antagonist activity, as well as a method for identifying (+)-morphinans that may be therapeutically effective by determining whether the (+)-morphinan inhibits the activation of TLR9. Also provided are methods of using the (+)-morphinans comprising TLR9 antagonist activity to treat conditions such as traumatic pain, neuropathic pain, inflammatory disorders, acetaminophen toxicity, autoimmune disorders, neurodegenerative disorders, and cancer.
Abstract: The present invention provides 3-oxy-hydromorphone derivatives, and in particular, 3-ester, 3-carbonate, and 3-sulfonate derivatives of hydromorphone.
Type:
Application
Filed:
July 9, 2010
Publication date:
January 20, 2011
Applicant:
Mallinckrodt Inc.
Inventors:
Gary L. Cantrell, Robert E. Halvachs, Frank W. Moser, David W. Berberich, Peter X. Wang
Abstract: The present invention provides processes for the enrichment of buprenorphine in a product. In particular, the present invention provides processes for the enrichment of buprenorphine in a product using chromatographic techniques.
Abstract: The present invention relates to management of information relating to medical fluids, containers therefore, and medical fluid administration devices for administering such medical fluids to patients. Data tags (e.g., RFID tags) are generally associated with containers of the invention and may be electromagnetically read from and/or written to using an electromagnetic device, for example, that may be associated with a medical fluid administration device of the invention.
Abstract: The present invention provides processes for the stereoselective synthesis of 6-alpha-amino N-substituted morphinans. In particular, the invention provides processes for the reductive amination of 6-keto N-substituted morphinans by catalytic hydrogen transfer.
Type:
Application
Filed:
June 10, 2010
Publication date:
December 16, 2010
Applicant:
Mallinckrodt Inc.
Inventors:
Christopher W. Grote, Gary L. Cantrell, Joseph P. McClurg, Catherine E. Thomasson, Frank W. Moser
Abstract: There is disclosed a novel sustained release granular resin-pharmaceutical composition comprising an ion exchange resin complexed with a pharmaceutical material wherein said complex is embedded into and on the surface of a diffusion barrier material. There is also disclosed a novel process for preparing the granulated complex wherein an aqueous granulating vehicle is employed to form the complex and the granulated product, thereby avoiding the use of coatings and large amounts of organic solvents in the process.
Abstract: The present invention provides processes for the stereoselective synthesis of 6-alpha-amino morphinans. In particular, the invention provides processes for the reductive amination of 6-keto normorphinans by catalytic transfer hydrogenation.
Type:
Application
Filed:
June 10, 2010
Publication date:
December 16, 2010
Applicant:
Mallinckrodt Inc.
Inventors:
Christopher W. Grote, Gary L. Cantrell, Joseph P. McClurg, Catherine E. Thomasson, Frank W. Moser
Abstract: The present invention provides a process for the production of goserelin. In particular, the process of the invention allows the use of side chain protecting groups during synthesis of the peptide, and the addition of the azaglycine moiety of the peptide.